JPMorgan · 2023-11-01 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-08-01 | +$107,591 | — | — | $9.0M | 每日估算 |
| 2026-07-31 | -$221,850 | — | — | $9.0M | 每日估算 |
| 2026-07-30 | +$230,944 | — | — | $9.3M | 每日估算 |
| 2026-07-29 | -$146,397 | — | — | $9.2M | 每日估算 |
| 2026-07-28 | +$51,872 | — | — | $9.1M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
Eli Lilly & Co. Eli Lilly & Co. | EC | 811 | $757,961 | 6.81% |
AbbVie, Inc. AbbVie, Inc. | EC | 3,464 | $732,012 | 6.58% |
Johnson & Johnson Johnson & Johnson | EC | 3,001 | $689,780 | 6.20% |
UnitedHealth Group, Inc. UnitedHealth Group, Inc. |
行情与风险截至 2026-07-31；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-27 | -$29,065 | — | — | $9.0M | 每日估算 |
| 2026-07-26 | -$29,065 | — | — | $9.0M | 每日估算 |
| 2026-07-25 | -$86,888 | — | — | $9.0M | 每日估算 |
| 2026-04-30 | +$1.4M | $1.4M | $0 | $11.1M | SEC 月度 |
| 2026-03-31 | +$1.3M | $1.3M | $0 | — | SEC 月度 |
| 2026-02-28 | $0 | $0 | $0 | — | SEC 月度 |
| EC |
| 1,751 |
| $648,710 |
| 5.83% |
AstraZeneca plc AstraZeneca plc | EC | 2,677 | $507,887 | 4.57% |
Merck & Co., Inc. Merck & Co., Inc. | EC | 4,289 | $468,273 | 4.21% |
Bristol-Myers Squibb Co. Bristol-Myers Squibb Co. | EC | 6,427 | $389,412 | 3.50% |
Thermo Fisher Scientific, Inc. Thermo Fisher Scientific, Inc. | EC | 740 | $354,430 | 3.19% |
Intuitive Surgical, Inc. Intuitive Surgical, Inc. | EC | 719 | $329,022 | 2.96% |
CVS Health Corp. CVS Health Corp. | EC | 3,618 | $301,343 | 2.71% |
Novo Nordisk A/S, Class B Novo Nordisk A/S, Class B | EC | 6,943 | $295,327 | 2.65% |
Roche Holding AG Roche Holding AG | EC | 723 | $294,623 | 2.65% |
Hoya Corp. Hoya Corp. | EC | 1,400 | $261,441 | 2.35% |
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. | EC | 344 | $243,229 | 2.19% |
Boston Scientific Corp. Boston Scientific Corp. | EC | 3,946 | $227,329 | 2.04% |
UCB SA UCB SA | EC | 803 | $218,650 | 1.97% |
Vertex Pharmaceuticals, Inc. Vertex Pharmaceuticals, Inc. | EC | 510 | $217,964 | 1.96% |
Danaher Corp. Danaher Corp. | EC | 1,184 | $211,877 | 1.90% |
Edwards Lifesciences Corp. Edwards Lifesciences Corp. | EC | 2,435 | $203,323 | 1.83% |
McKesson Corp. McKesson Corp. | EC | 243 | $198,094 | 1.78% |
Stryker Corp. Stryker Corp. | EC | 562 | $177,103 | 1.59% |
Argenx SE Argenx SE | EC | 218 | $170,962 | 1.54% |
Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. | EC | 4,466 | $156,986 | 1.41% |
Cardinal Health, Inc. Cardinal Health, Inc. | EC | 796 | $153,532 | 1.38% |
Centene Corp. Centene Corp. | EC | 2,739 | $147,057 | 1.32% |
Biogen, Inc. Biogen, Inc. | EC | 764 | $144,610 | 1.30% |
Zoetis, Inc. Zoetis, Inc. | EC | 1,136 | $130,606 | 1.17% |
United Therapeutics Corp. United Therapeutics Corp. | EC | 226 | $129,125 | 1.16% |
Lonza Group AG (Registered) Lonza Group AG (Registered) | EC | 200 | $122,964 | 1.11% |
Novartis AG (Registered) Novartis AG (Registered) | EC | 783 | $115,719 | 1.04% |
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA | EC | 2,383 | $115,408 | 1.04% |
IQVIA Holdings, Inc. IQVIA Holdings, Inc. | EC | 726 | $114,977 | 1.03% |
Sartorius AG (Preference) Sartorius AG (Preference) | EC | 398 | $101,680 | 0.91% |
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. | EC | 1,327 | $98,795 | 0.89% |
Apogee Therapeutics, Inc. Apogee Therapeutics, Inc. | EC | 1,152 | $95,489 | 0.86% |
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. | EC | 1,257 | $93,973 | 0.84% |
Argenx SE Argenx SE | EC | 116 | $90,970 | 0.82% |
CG oncology, Inc. CG oncology, Inc. | EC | 1,304 | $87,029 | 0.78% |
Ascendis Pharma A/S Ascendis Pharma A/S | EC | 343 | $78,677 | 0.71% |
Align Technology, Inc. Align Technology, Inc. | EC | 437 | $76,916 | 0.69% |
Immunome, Inc. Immunome, Inc. | EC | 3,351 | $76,872 | 0.69% |
Dyne Therapeutics, Inc. Dyne Therapeutics, Inc. | EC | 4,266 | $74,868 | 0.67% |
JPMorgan Securities Lending Money Market Fund, Class Agency SL Shares JPMorgan Securities Lending Money Market Fund, Class Agency SL Shares | STIV | 71,313 | $71,313 | 0.64% |
Dexcom, Inc. Dexcom, Inc. | EC | 1,196 | $71,222 | 0.64% |
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. | EC | 533 | $70,180 | 0.63% |
Genmab A/S Genmab A/S | EC | 265 | $70,166 | 0.63% |
Daiichi Sankyo Co. Ltd. Daiichi Sankyo Co. Ltd. | EC | 4,200 | $68,225 | 0.61% |
Convatec Group plc Convatec Group plc | EC | 23,481 | $67,339 | 0.61% |
Cigna Group (The) Cigna Group (The) | EC | 231 | $67,124 | 0.60% |
Medtronic plc Medtronic plc | EC | 808 | $65,424 | 0.59% |
Alumis, Inc. Alumis, Inc. | EC | 2,446 | $60,392 | 0.54% |
Nuvalent, Inc., Class A Nuvalent, Inc., Class A | EC | 584 | $58,564 | 0.53% |
Bio-Techne Corp. Bio-Techne Corp. | EC | 843 | $46,635 | 0.42% |
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. | EC | 1,201 | $46,479 | 0.42% |
Disc Medicine, Inc. Disc Medicine, Inc. | EC | 636 | $41,944 | 0.38% |
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. | EC | 112 | $34,663 | 0.31% |
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. | EC | 2,323 | $31,314 | 0.28% |
Evommune, Inc. Evommune, Inc. | EC | 1,260 | $29,988 | 0.27% |
Xenon Pharmaceuticals, Inc. Xenon Pharmaceuticals, Inc. | EC | 535 | $29,981 | 0.27% |
HCA Healthcare, Inc. HCA Healthcare, Inc. | EC | 68 | $29,543 | 0.27% |
Genmab A/S Genmab A/S | EC | 523 | $13,870 | 0.12% |
Swiss Franc Swiss Franc | STIV | 0 | $0 | 0.00% |
Danish Krone Danish Krone | STIV | -0 | $0 | 0.00% |
Japanese Yen Japanese Yen | STIV | -1 | -$0 | -0.00% |
British Pound British Pound | STIV | -0 | -$0 | -0.00% |
EURO EURO | STIV | -1 | -$1 | -0.00% |